- Home
- ORIC vs GNE Comparison
ORIC vs GNE Comparison
Compare ORIC & GNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- GNE
- Stock Information
- Founded
- ORIC 2014
- GNE 2011
- Country
- ORIC United States
- GNE United States
- Employees
- ORIC N/A
- GNE N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- GNE Power Generation
- Sector
- ORIC Health Care
- GNE Utilities
- Exchange
- ORIC Nasdaq
- GNE Nasdaq
- Market Cap
- ORIC 362.9M
- GNE 718.9M
- IPO Year
- ORIC 2020
- GNE N/A
- Fundamental
- Price
- ORIC $10.21
- GNE $26.76
- Analyst Decision
- ORIC Strong Buy
- GNE
- Analyst Count
- ORIC 8
- GNE 0
- Target Price
- ORIC $18.83
- GNE N/A
- AVG Volume (30 Days)
- ORIC 1.2M
- GNE 311.1K
- Earning Date
- ORIC 08-11-2025
- GNE 08-05-2025
- Dividend Yield
- ORIC N/A
- GNE 1.12%
- EPS Growth
- ORIC N/A
- GNE 10.33
- EPS
- ORIC N/A
- GNE 0.55
- Revenue
- ORIC N/A
- GNE $442,321,000.00
- Revenue This Year
- ORIC N/A
- GNE $13.72
- Revenue Next Year
- ORIC N/A
- GNE $6.96
- P/E Ratio
- ORIC N/A
- GNE $48.43
- Revenue Growth
- ORIC N/A
- GNE N/A
- 52 Week Low
- ORIC $3.90
- GNE $13.05
- 52 Week High
- ORIC $14.67
- GNE $28.47
- Technical
- Relative Strength Index (RSI)
- ORIC 63.99
- GNE 70.44
- Support Level
- ORIC $10.05
- GNE $25.83
- Resistance Level
- ORIC $10.99
- GNE $28.08
- Average True Range (ATR)
- ORIC 0.60
- GNE 1.16
- MACD
- ORIC -0.07
- GNE -0.06
- Stochastic Oscillator
- ORIC 54.67
- GNE 68.68
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About GNE Genie Energy Ltd. Class B Stock
Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.